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Excitotoxin 
Lathyrism, a human neurological disorder has been linked to the excessive consumption of a plant toxin, p-oxalylamino-L-alanine CL-BOAA) 
present in Lathyrus sativus. The present study was carried out to elucidate the biochemical mechanisms underlying L-BOAA-induced toxic insult. 
Incubation of sagittal slices of mouse brain with L-BOAA resulted in dose and time-dependent inhibition of mitochondrial NADH-dehydro- 
genase (NADH-DH). Significant inhibition of NADH-DH was seen following incubation of brain slices with very low concentration of L-BOAA 
(0.1 PM). L-BOAA also induced lactate dehydrogenase (LDH) leakage from the slice into the medium in dose-dependent manner. The inhibition 
of NADH-DH preceded LDH leakage from the slices into the medium. L-BOAA had no effect on other mitochondrial enzymes, namely, 
isocitrate dehydrogenase or cytochrome c oxidase. Incubation of isolated mouse brain mitochondria with L-BOAA also resulted in inhibition of 
NADH-DH. L-BOAA-induced inhibition of NADH-DH was prevented by non-N-methyl-o-aspartate (non-NMDA) glutamate receptor antago- 
nists in general and a-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor antagonist (NBQX) in particular. Other glutamate 
agonists examined namely, N-methyl-p-aspartate, /?-N-methylamino-L-alanine (L-BMAA), L-glutamic acid, N-acetylaspartylglutamate (NAAG), 
quisqualic acid, kainic acid or AMPA did not have any effect on NADH-DH activity in slices although they induced LDH leakage from the slice 
into the medium. Incubation of brain slices with L-BOAA did not induce lipid peroxidation or changes in glutathione levels. Prior incubation of 
slices with glutathione (GSH) or GSH-isopropyl ester did not prevent L-BOAA-induced inhibition of NADH-DH. However, incubation of 
isolated mitochondria with L-BOAA in the presence of GSH-isopropyl ester prevented L-BOAA-induced inhibition of NADH-DH, indicating the 
protective effect of mitochondrial glutathione in the prevention of L-BOAA-induced toxicity. 
INTRODUCTION 
The study of molecular mechanisms underlying neu- 
rodegenerative disorders has been an area of extensive 
investigation. Ingestion of neurotoxic excitatory amino 
acid L-BOAA~~, present in Lathyrus sativusz4, has 
been implicated in human neurodegenerative disorder 
‘lathyrism”3,32. Administration of L-BOAA to primates 
elicited motor neuron disorder similar to that seen in 
humans3’. Brain and retinal degeneration have been 
reported following administration of L-BOAA to 
mouse’9. Postsynaptic vacuolation and dark, shrunken 
cells were seen after incubation of explant cultures of 
mouse brain and spinal cord with L-BOAA”‘*‘. Consid- 
erable efforts have been made to understand the mech- 
anism of the toxic action of L-BOAA. Non-NMDA 
class of glutamate receptor antagonists selectively block 
L-BOAA induced toxic insult both in vitro and in vivo 
indicating that L-BOAA probably acts through excita- 
tory amino acid receptors26,27,38. However, the bio- 
chemical sequelae leading to toxic damage following 
receptor activation is still unclear. 
The present study was carried out to evaluate 
molecular mechanisms underlying L-BOAA induced 
toxicity in mouse brain slices and to compare it with 
other glutamate receptor agonists. 
Sagittal slices of rodent brain provide a good in vitro 
model for mechanistic evaluation of neurotoxicity. The 
selectivity and sensitivity of this model has been estab- 
lished using a variety of neurotoxins20y21V25 including 
excitatory amino acid . 2o Hence, this in vitro model was 
chosen for the present study. 
The generation of oxidative stress by excitotoxic 
amino acids has been demonstrated’*. The generation 
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of oxidative stress would result in loss of protein thiols 
leading to inhibition of vital enzymes which contain the 
thiol groups in their active site. More recently, the vital 
mitochondrial enzyme, NADH-dehydrogenase has 
been shown to be inhibited following exposure to reac- 
tive oxygen species 41 The present study proposes to . 
examine the effect of L-BOAA on the above enzyme 
using an in vitro model consisting of sagittal slices of 
mouse brain. 
MATERIALS AND METHODS 
Materials 
L-BOAA, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 6,7-di- 
nitroquinoxaline-2,3-dione (DNQX), 5-methyl-lO,ll-dehydro-SH- 
benzo ((u, 6) cyclohepten-5-lo-imine maleate [( + )MK-80111, NMDA, 
AMPA, kainic acid and L-BMAA were obtained from Research 
Biochemical Inc., USA. Glutamate diethyl ester (GDEE) was pro- 
cured from Sigma Chemical Co., USA. 2,3-Dihydroxy-6-nitro-7- 
sulfamoyl-benzo(F)quinoxaline (NBQX) was a gift from Novo 
Nordisk, Denmark. Glutathione (GSHJ-isopropyl ester was a kind 
gift from Yamanouchi Pharmaceuticals Co. Ltd., Japan. 
Methods 
Swiss Albino mice (3-4 months old) weighing 25-30 g were used 
for all experiments. Animals were obtained from NIMHANS Central 
Animal Research Facility and had free access to pelleted diet (Lip- 
ton India Ltd., Bombay) and water ad libitum. Following decapita- 
tion, brains were quickly removed and sagittal slices of uniform 
thickness (0.5 mm) were prepared using a slicer’*. Four sagittal slices 
were obtained from each mouse brain. Brain slices were incubated in 
artificial cerebrospinal fluid (ACSF, pH 7.4; 1.5 ml/slice) containing 
(in mM): NaCl 124, KC1 5, MgSO, 1.3, CaCl, 1.3 glucose 10, 
KH,PO, 1.2 and glycylglycine 30 or NaHCO, 25, with and without 
L-BOAA. Incubations were carried out in an atmosphere of oxygen 
at 37°C. In some experiments, incubations were carried out in ACSF 
in which magnesium was absent, but was otherwise similar. To study 
the effect of glutathione (GSH) or GSH-isopropyl ester on L-BOAA 
toxicity, slices were preincubated with GSH (10 mM) or GSH-isopro- 
pyl ester (1 mM) for 30 min prior to addition of L-BOAA (10 PM). At 
the end of the incubation period, slices were removed, rinsed and 
homogenized in 0.32 M sucrose. The homogenate was centrifuged at 
1,000X g for 10 min to remove cell debris. The supernatant was used 
for the assay of enzyme activity. Following incubation, the ACSF was 
filtered and used for the estimation of LDH activity. 
Measurement of NADH-DH activity. Brain homogenate was freeze 
thawed twice and 90-120 pg of the protein was used for the assay. 
The assay mixture consisted of phosphate buffer (0.05 M, pH 7.6) 
containing sucrose (0.25 M) and the brain homogenate. The reaction 
was initiated by the addition of NADH (0.28 mM) and the rate of 
change of absorbance at 340 nm was monitored as described21,2’. 
Assay of LDH. The leakage of LDH from the slices into the 
medium following incubation with excitatory amino acids was mea- 
sured as described *‘,” Twenty microliters of ACSF medium was 
added to 980 ~1 of phosphate buffer (0.05 M, pH 7.4) containing 0.65 
mM pyruvate and 11.33 mM NADH and the change in absorbance 
was monitored at 340 nm. 
Activities of isocitrate dehydrogenase (ICDH), cytochrome c oxi- 
dase were estimated as describedz5. 
Glutathione was measured by enzymatic recycling method’ and 
malondialdehyde was measured as thiobarbituric acid reactive prod- 
ucts”. Protein was estimated using a dye-binding method*. 
The brain slices were preincubated with glutamate receptor an- 
tagonists, namely, (+)MK-801 (1 nM), GDEE (100 PM), DNQX (1 
PM), CNQX (1 PM) or NBQX (1 PM) for 30 min at 37°C. Following 
preincubation, L-BOAA (1 pM) was added and the incubation was 
continued for 1 hr. The effect of NBQX or CNQX on t-BOAA-in- 
duced damage was also examined by injecting NBQX or CNQX (30 
mg/kg body weight), subcutaneously to mice. The animals were 
sacrificed 4 h after the injection of quinoxalinediones and sagittal 
slices of brain were prepared from the quinoxalinedione treated 
mice. The slices were incubated with and without L-BOAA (10 pM) 
for 1 h at 37°C. Similar experiments were also carried out using brain 
slices from untreated mice. 
Isolation of mitochondria. Mouse brain mitochondria was isolated 
as described by Sims3’ with certain modifications. Animals were 
anaesthetized prior to decapitation with ether and perfused transcar- 
dially with ice cold buffer (0.1 M Tris-HCl containing 1.15% KCl, pH 
7.4). The brains were rapidly removed and the mitochondrial fraction 
was isolated using Percoll gradient. Isolation medium contained 0.32 
M sucrose, 0.1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 0.1 
mM 1,4-dithio-o,L-threitol in 10 mM Tris-HCI (pH 7.4). The mito- 
chondrial pellet obtained using the above procedure was relayered 
on a similar discontinuous Percoll density gradient and the process 
was repeated to obtain pure mitochondria. The mitochondria was 
suspended in incubation medium consisting of potassium phosphate 
buffer (3 mM, pH 7.4) containing HEPES (4 mMl, EDTA (1 mM), 
sucrose (0.25 M), malic acid WlO PM), glutamic acid (100 PM) and 
mercaptoethanol (5 mM). Freshly isolated mitochondria were incu- 
bated with L-BOAA (10 PM), GSH-isopropyl ester (1 mM) or GSH- 
isopropyl ester (1 mM) and L-BOAA (10 PM) for one hour at 37°C in 
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Fig. 1. Dose-dependent effect of L-BOAA on NADH-DH activity in slices and the leakage of LDH from mouse brain slices into the medium. 
Mouse brain slices were incubated with various concentrations of L-BOAA for 1 h at 37°C under an atmosphere of oxygen. Following incubation, 
NADH-DH activity was measured in slice homogenate and leakage of LDH from the slices into the medium was monitored. Values are 
mean f S.D. (n = 4-8). Asterisks represent values significantly different from controls (P < 0.05). 
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an atmosphere of oxygen. After the incubation, NADH-DH activity 
was measured in the mitochondrial suspension. 
Statistical analysis was carried out using students t-test or Analy- 
sis-of-variance (ANOVA) with Duncan’s test where appropriate. 
RESULTS 
Incubation of mouse brain slices with various con- 
centrations of L-BOAA resulted in dose-dependent 
decrease of NADH-DH activity (Fig. 1). Significant 
inhibition was noted when the slices were incubated 
with 0.1 pM L-BOAA. NADH-DH activity decreased 
thereafter in a dose-dependent manner and maximum 
inhibition (52%) was observed when L-BOAA concen- 
tration in the incubation medium was 10 PM. Incuba- 
tion of mouse brain slices with L-BOAA also resulted 
in dose-dependent leakage of LDH from the slice into 
the medium (Fig. 1). Significant leakage of LDH from 
the slice into the medium was seen when L-BOAA 
concentration in the medium was 1 pM indicating that 
NADH-DH inhibition preceded LDH leakage. 
Mouse brain slices were incubated for various time 
intervals (15-60 min) with and without 10 pM L-BOAA 
(Fig. 2). L-BOAA-induced inhibition of NADH-DH 
activity (16%) in slices was observed following 30 min 
incubation (Fig. 2). When the slices were incubated 
with L-BOAA for longer periods (60 min), enhanced 
inhibition of NADH-DH (36%) was observed. 
In order to determine if L-BOAA had any effect on 
other mitochondrial enzymes, higher concentrations of 
L-BOAA (10 pM-10 PM) were added to the ASCF 
medium containing mouse brain slices and incubated 
for 1 h at 37°C under oxygen. Even after incubation of 
slices with a very high concentration of L-BOAA (10 
FM), the activity of other mitochondrial enzymes, 
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Fig. 2. Effect of incubation time on L-BOAA induced NADH-DH 
inhibition in brain slices. Mouse brain slices were incubated with 
L-BOAA (10 pM) for 15, 30 and 60 min. NADH-DH activity in the 
slice was monitored following the incubation. Slices incubated with- 
out L-BOAA served as controls. Values are mean f SD. (n = 4-6). 
Asterisks represents values significantly different from corresponding 
controls (P < 0.05). 
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Fig. 3. Effect of L-BOAA on isocitrate dehydrogenase and cy- 
tochrome c oxidase activity. Isocitrate dehydrogenase and cy- 
tochrome c oxidase activity were measured in the slice homogenate 
following incubation of mouse brain slices with various concentra- 
tions of L-BOAA for 1 h at 37°C. Values are mean f S.D. (n = 4). 
namely, isocitrate dehydrogenase (ICDH) and cy- 
tochrome c oxidase remained unaffected as shown in 
Fig. 3. However, the activities of the lysosomal en- 
zymes, N-acetylglucosaminidase and acid phosphatase 
were inhibited significantly after incubation with 10 
pM L-BOAA (data not shown). 
Mouse brain slices were preincubated with gluta- 
mate receptor antagonists, namely, ( + )MK-801 
(NMDA receptor antagonist) or GDEE (non-NMDA 
receptor antagonist) for 30 min at 37°C. Following 
preincubation, L-BOAA (1pM) was added to one set of 
slices and the incubation was continued further for 1 h. 
GDEE completely protected the slices against the toxic 
action of L-BOAA by preventing inhibition of NADH- 
DH, while ( + )MK-801 had no effect even at high 
concentration (100 nM; Table I). In order to test the 
efficacy of other non-NMDA receptor antagonists 
(namely quinoxalinediones) in protecting against L- 
BOAA induced toxicity, NBQX or CNQX were admin- 
istered subcutaneously to mice (30 mg/kg body weight) 
and one set of slices prepared from drug treated ani- 
mals were incubated with L-BOAA (10 PM) for 1 h at 
37°C. The other set served as control. Both NBQX and 
CNQX protected against L-BOAA induced inhibition 
of NADH-DH (Table I). CNQX and NBQX did not 
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protect the slices from L-BOAA-induced toxicity when 
added in vitro. However, preincubation of mouse brain 
slices with DNQX (1 PM) for 30 min at 37°C protected 
the slices against L-BOAA-induced inhibition of 
NADH-DH (Table I). 
To examine the effect of other glutamate receptor 
agonists on NADH-DH activity, mouse brain slices 
were incubated with NMDA, L-BMAA, L-glutamic acid, 
NAAG, quisqualic acid, kainic acid or AMPA for 1 h 
at 37°C. None of the glutamate agonists examined 
inhibited NADH-DH activity (Table II). The minimum 
toxic dose of glutamate agonists required to induce 
significant LDH leakage is also given in Table II. The 
doses of agonists used were substantially higher than 
the minimum toxic dose in all cases, except L-BMAA. 
The effect of varying concentration of L-BOAA on 
the levels of glutathione and lipid peroxidation prod- 
ucts (measured as malondialdehyde) in brain slices is 
depicted in Table III. Incubation with L-BOAA did not 
result in any significant change in the levels of glu- 
tathione or malondialdehyde in the slices. 
The effect of prior incubation of brain slices with 
GSH or GSH-isopropyl ester on L-BOAA-induced in- 
hibition of NADH-DH is described in Table IV. Both 
GSH and GSH-isopropyl ester failed to protect the 
slices from L-BOAA-induced inhibition of NADH-DH. 
TABLE I 
Effect of glutamate receptor antagonists on L-BOAA induced inhibition 
of NADH-DH actiuiiy in mouse brain slices 
NADH-DH activity 
Control 
- BOAA + BOAA 
14.5 + 0.2 12.lkO.4 * 
NMDA antagonist 
MK-801 (1 nM) 13.4kO.7 10.6+0.1 * 
MK-801tlOO nM) 13.6 + 0.1 10.4+ 1.8 * 
Non-NMDA antagonists 
GDEE (100 /.LM) 14.5 YLo.7 14.0+_ 1.0 
DNQX (1 PM) 14.5 f 0.8 13.7+ 1.2 
CNQX (1 PM) 14.2 f 1.6 11.2+ 1.7 * 
CNQX (30 mg/kg body wt. s.c.) 14.5 + 0.3 14.2 + 0.9 
NBQX (1 /JM) 14.4+0.6 12.4 f 0.5 * 
NBQX (30 mg/kg body wt. s.c.) 14.7i 1.2 15.0+0.1 
Mouse brain slices were preincubated with MK-801, GDEE, CNQX, 
DNQX or NBQX for 30 min at 37°C. The concentration of the 
antagonists used is given in parenthesis. Following preincubation, 
L-BOAA (1 pM) was added to one set of slices and the incubations 
were continued further for a period of 1 h. CNQX or NBQX were 
injected (30 mg/kg body weight) to mice subcutaneously (s.c) and 
sacrificed 4 h later. Brain slices prepared from treated mice were 
incubated with L-BOAA (10 PM). Slices from untreated animals 
were also incubated simultaneously. NADH-DH activity was mea- 
sured in the slice homogenate at the end of incubation period and is 
expressed as nmoles of NADH oxidized/min/mg protein. Values 
are mean + SD (n = 4-6). Asterisks represent values significantly 
different from corresponding controls (P < 0.05). 
TABLE II 
Effect of various glutamate receptor agonists on NADH-DH activity in 
mouse brain slices 
Agonist NADH-DH 
activity 
Minimum dose needed 
for significant 
leakage of LDH 
None (Control) 
L-BOAA (0.1 pM) 
L-Glutamate (1 mM) 
NAAG (1 PM) 
L-BMAA (1 mM) 
NMDA (1 /.LM) 
Quisqualic acid (1 FM) 
AMPA (1 mM) 
Kainic acid (1 mM) 
14.7 f 1.2 - 
12.8+0.7 * 1.0 pM 
14.2& 1.2 10 pM 
14.9 + 1.4 0.1 pM 
14.0+_1.2 1 mM 
15.0$- 1.1 1 nM 
14.4*0.9 1 nM 
15.5+1.1 100 PM 
14.4 + 0.9 1 uM 
Mouse brain slices were incubated with L-BOAA, L-glutamate, 
NAAG, L-BMAA, NMDA, quisqualic acid, AMPA and kainic acid 
for 1 h at 37°C. NADH-DH activity was measured in the slice 
homogenate following incubation and is expressed as nmol of NADH 
oxidized/min/mg protein. Values are mean _+ SD (n = 4-S). Aster- 
isks represent values significantly different from controls (P < 0.05). 
TABLE III 
The effect of L-BOAA on the concentration of glutathione and malon- 
dialdehyde in brain slices 
GSH Malondialdehyde 
(p mol/ g tissue) (nmol/ g tissue) 
Control 1.74kO.2 46.3 + 3.1 
L-BOAA (1 PM) 1.57+0.1 43.7 + 4.9 
L-BOAA (1 nM) 1.73 + 0.2 50.3 + 2.6 
L-BOAA (1 PM) 1.69kO.2 51.0i.5.4 
Brain slices were incubated with various concentrations of L-BOAA 
(1 pM-1 FM) for 1 h at 37°C. Following incubation the concentra- 
tions of GSH and malondialdehyde were measured in slices. Values 
are mean + SD. (n = 4-6). 
Prior incubation with GSH or GSH-isopropyl ester 
alone had no effect on the NADH-DH activity in brain 
slices. 
TABLE IV 
Effect of preincubation of brain slices with glutathione or glutathione- 
isopropyl ester on L-BOAA induced NADH-DH inhibition 
NADH-DH 
(70 control) 
Control 100 f6.1 
L-BOAA 80.7k5.4 * 
GSH 99.4 + 3.3 
GSH + L-BOAA 8O.Ok4.9 * 
GSH - isopropyl ester 101.4 _+ 4.1 
GSH - isopropyl ester + L-BOAA 81.9k6.4 * 
Mouse brain slices were preincubated with GSH (10 mM) or GSH- 
isopropyl ester (1 mM) for 30 min at 37°C. L-BOAA (10 PM) was 
added to one set of slices and the incubation was further continued 
for 1 h. Slices incubated in ACSF alone were also run simultane- 
ously. The NADH-DH activity in slices incubated in ACSF was 
15.7 f 0.7 nmol/min/mg protein. Values are mean + SD. (n = 4-8). 
Asterisks represent values significantly different from corresponding 
controls (P < 0.05). 
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TABLE V 
Effect of L-BOAA on NADH-DH activity in isolated mouse brain 
mitochondn’a 
Control 
L-BOAA 
GSH-isopropyl ester 
GSH-isopropyl ester + L-BOAA 
NADH-DH activity 
38.6+ 3.2 
29.6+ 1.8 * 
38.6 f 0.8 
37.9 f 0.9 
Freshly isolated mitochondria from mouse brain were incubated with 
L-BOAA (10 PM), GSH-isopropyl ester (1 mM) or GSH-isopropyl 
ester (1 mM) and L-BOAA (10 pM) for 1 h at 37°C in an atmosphere 
of oxygen. Following incubation, mitochondria were freeze thawed 
twice and used for NADH-DH assay. NADH-DH activity is ex- 
pressed as nmoles of NADH oxidized/min/mg protein. Asterisks 
represent values significantly different from controls (P < 0.05). Val- 
ues are mean + S.D. (n = 6). 
Incubation of freshly isolated mitochondria with L- 
BOAA (10 PM) for 1 h at 37°C resulted in significant 
inhibition (23%) of NADH-DH activity (Table V>. Ad- 
dition of GSH-isopropyl ester to the incubation medium 
abolished L-BOAA-induced inhibition of NADH-DH 
activity in the mitochondria (Table V). 
DISCUSSION 
The present study demonstrates the selective inhibi- 
tion of mitochondrial enzyme, NADH-DH by L-BOAA, 
in vitro, in mouse brain slices. Incubation of mouse 
brain slices with L-BOAA resulted in dose and time- 
dependent inhibition of NADH-DH activity (Figs. 1 
and 2). NADH-DH activity was inhibited in the slices 
following incubation with very low concentrations of 
L-BOAA (0.1 PM). The study of dose-dependent ef- 
fects indicated that the inhibition of NADH-DH pre- 
ceded the leakage of cytosolic enzyme LDH, suggesting 
that mitochondrial damage occurred prior to LDH 
leakage. The inhibition of NADH-DH by L-BOAA was 
selective, as other mitochondrial enzyme activities, 
namely isocitrate dehydrogenase and cytochrome c oxi- 
dase remained unaffected following incubation of 
mouse brain slices with very high concentrations of 
L-BOAA (10 PM, Fig. 3). Inhibition of NADH-DH 
activity was also observed following incubation of 
freshly isolated mouse brain mitochondria with L- 
BOAA (Table V). The maximum inhibition of NADH- 
DH observed was 51% after exposure to 10 PM L- 
BOAA. Further increase in the concentrations of L- 
BOAA did not result in greater inhibition of NADH- 
DH. These unusual kinetics are observed with the most 
neurotoxins20,21 which exert their action on selective 
populations of cells within specific regions of the brain. 
Mouse brain slices were incubated with various glu- 
tamate receptor agonists, namely, NMDA16, L-BMAA~~, 
L-glutamate35, NAAG5,39, quisqualic acid’, kainic acid29 
or AMP&,” to determine their effect on NADH-DH 
activity (Table II). NMDA was found to have no effect 
on NADH-DH activity following incubation with brain 
slices. Incubations with NMDA were carried out in 
ACSF with and without magnesium and incubations 
with L-BMAA were carried out in ACSF which con- 
tained sodium bicarbonate or glycylglycine. L-BMAA, 
(a structural analogue of L-BOAA), has been impli- 
cated in the pathogenesis of Guam amyotrophic lateral 
sclerosis-Parkinson’s dementia complex33. L-BMAA 
had no effect on NADH-DH activity. Similar results 
were also observed with L-glutamate or NAAG, an 
endogenous excitatory dipeptide, recently shown to 
possess neurotoxic effects 2o Kainic acid, quisqualic .
acid, and AMPA (known to activate kainate and AMPA 
receptors, respectively) also did not inhibit NADH-DH 
activity. These results demonstrate that L-BOAA selec- 
tively inhibits NADH-DH activity in mouse brain slices 
and that the mechanism by which L-BOAA exerts its 
toxic action may be different from that of other gluta- 
mate agonists. 
Excitatory amino acids mediate their toxic action by 
acting on the NMDA or non-NMDA class of glutamate 
receptors . 4,15 Excitotoxicity of L-BOAA is mediated via 
the non-NMDA class of glutamate receptors27*38. Inhi- 
bition of L-BOAA toxicity by various non-NMDA re- 
ceptor antagonists and receptor binding studies have 
been used to demonstrate that the mechanism of ac- 
tion of L-BOAA probably involves activation of AMPA 
receptors . 27,28,38 In the present study, GDEE, a non 
specific non-NMDA receptor antagonist37, protected 
L-BOAA-induced inhibition of NADH-DH activity. 
NMDA receptor antagonist ( + )MK-80134 did not have 
any effect on L-BOAA-induced mitochondrial toxicity 
even at high concentration (100 nM). Recently quinox- 
alinediones, a new class of drugs known to selectively 
block quisqualate/AMPA receptors have been used to 
differentiate NMDA and non-NMDA receptor medi- 
ated responses8,30. Quinoxalinediones, namely, CNQX, 
DNQX and a more selective AMPA antagonist NBQX, 
were used in the present study to observe their effect 
on L-BOAA-induced inhibition of NADH-DH activity. 
NBQX and CNQX protected the slices against L- 
BOAA-induced NADH-DH inhibition, when adminis- 
tered in vivo (Table I). However, these drugs did not 
offer protection to the slices against L-BOAA-induced 
toxicity when added in vitro. But, DNQX protected the 
slices against L-BOAA-induced toxicity when added in 
vitro. The reason for the differential effect of the 
quinoxalinediones is unclear. Earlier studies on the 
effect of NBQX in protecting against ischemic injury 
also involved injection of NBQX, in vivo3”. Neverthe- 
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less, experiments with quinoxalinediones clearly 
demonstrate that L-BOAA-induced inhibition of 
NADH-DH could be abolished by the quinoxaline- 
diones. The glutamate antagonists used in the present 
study namely, GDEE, CNQX, DNQX and NBQX did 
not have any effect on the NADH-DH activity in the 
slices when incubated alone with the brain slices. 
GSH, a major cellular protectant, maintains the 
thiol homeostasis in the cells14. Alteration in GSH 
levels may lead to membrane damage caused by free 
radicals6. In addition, depletion of GSH levels may 
also lead to oxidation of free thiol groups in the active 
sites of enzymes to disulfide linkages thereby inactivat- 
ing the enzyme 4o Involvement of oxidative stress in .
glutamate toxicity has been documented12. Since, 
NADH-DH contains cysteine residues in its active site3, 
oxidation of these thiol groups could result in inhibi- 
tion of enzyme activity as has been recently demon- 
strated in isolated mitochondria41. Hence, in order to 
determine if such peroxidative processes (where thiols 
are oxidized to disulphides) were involved in the inhibi- 
tion of NADH-DH by L-BOAA, we examined the 
status of GSH following exposure of slices to L-BOAA. 
Incubation of mouse brain slices with very high concen- 
trations of L-BOAA (1 PM) did not alter GSH levels in 
slices. There was no increase in malondialdehyde levels 
(indicative of lipid peroxidation) in L-BOAA (1 PM) 
treated slices (Table III). Further, prior incubation 
with GSH or GSH-isopropyl ester failed to protect the 
brain slices from L-BOAA-induced toxicity. However, 
addition of GSH-isopropyl ester to isolated mouse 
brain mitochondrial suspension prevented L-BOAA-in- 
duced inhibition of NADH-DH (Table V). Thus, addi- 
tion of GSH or GSH-isopropyl ester to slices may not 
have an effect on the mitochondrial GSH levels. The 
observations made with isolated mitochondria demon- 
strate that GSH-isopropyl ester can abolish the mito- 
chondrial toxicity of L-BOAA. 
Rat (Wistar, 3 months old) brain slices were incu- 
bated with various concentrations of L-BOAA. Signifi- 
cant increase in the leakage of LDH from the slices 
was observed only when the concentration of the toxin 
in the incubation medium was 1 nM, that is a thou- 
sand-fold higher than the least toxic dose required to 
produce similar response in mouse brain slices. There 
was no inhibition of NADH-DH activity even at high 
concentration of L-BOAA (1 PM, data not shown). 
These results demonstrate that there may be difference 
in the vulnerability of various species to the toxic 
action of L-BOAA. Similar effects between mice and 
rat have also been observed with MPTP, wherein the 
toxicity of MPTP, mediated via its metabolite MPP+ by 
inhibition of NADH-DH, is observed in mice but not 
in rats”. Further, the time course of inhibition of 
NADH-DH by both MPTP*i and by L-BOAA are 
similar, wherein significant inhibition of the enzyme is 
observed only after 30 min of incubation. 
The present study demonstrates that L-BOAA selec- 
tively inhibits mitochondrial NADH-DH, a property 
not shared by other glutamate agonists that were tested. 
This toxic effect was selectively blocked by non-NMDA 
receptor antagonists in general and AMPA receptor 
antagonist in particular. It may be presumed that L- 
BOAA acts through a novel non-NMDA class of gluta- 
mate receptor, which is sensitive to quinoxalinediones. 
However, this speculation is yet to be substantiated. 
Nevertheless, the excitotoxic mechanism underlying L- 
BOAA toxicity are probably not similar to other gluta- 
mate agonists that act through both NMDA and non- 
NMDA class of glutamate receptors. 
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